Bacterial STIs: The DoxyPEP Trial

STI Podcast

English - October 24, 2022 17:10 - 8 minutes - 7.54 MB - ★★★★ - 3 ratings
Science Health & Fitness Medicine medicine health interviews bmj debates conference roundtable british medical journal Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Presumptive and Prophylactic management of Bacterial STIs

Next Episode: HIV and STI prevention, plus HIV in Ukraine

Today we talk with the principal investigators of the DoxyPEP trial which was prematurely terminated due to its amazing success: participants receiving a stat dose of Doxycycline 200mg in less than 72 hours after condom-less sex were 63% less likely to develop a bacterial STI compared to participants in the control arm.
Prof Annie Leutkemeyer based in San Francisco (UCSF) and Prof Connie Celum, based in Seattle (WA)join Dr Fabiola Martin, STI's Podcast editor, in this short interview.

Please listen to a recent podcast on the wider subject of Bacterial STIs: https://soundcloud.com/bmjpodcasts/management-of-bacterial-stis?in=bmjpodcasts/sets/sti

Related links:
https://www.aidsmap.com/news/jul-2022/taking-antibiotic-after-sex-cuts-stis-two-thirds-doxypep-study-finds
academic.oup.com/cid/article/70/6/1247/5557867
www.ncbi.nlm.nih.gov/pmc/articles/PMC8360665/

To hear more episodes of the STI Podcast, please subscribe: https://podcasts.apple.com/gb/podcast/sti-podcast/id356342980